Skip to main content

Advertisement

Log in

Epidemiology of nasopharyngeal carcinoma: current insights and future outlook

  • REVIEW
  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Nasopharyngeal carcinoma (NPC) is characterised by its remarkable geographical and ethnic distribution. The interplay between genetic susceptibility, environmental exposures, and Epstein–Barr virus (EBV) infections is indicated in the development of NPC. Exposure to tobacco smoking, dietary factors, and inhalants has been associated with the risk of NPC. Genetic association studies have revealed NPC-associated susceptibility loci, including genes involved in immune responses, xenobiotic metabolism, genome maintenance, and cell cycle regulation. EBV exposure timing and strain variation might play a role in its carcinogenicity, although further investigations are required. Other factors including medical history and oral hygiene have been implicated in NPC. Prevention strategies, including primary prevention and secondary prevention through early detection, are vital in reducing mortality and morbidity of NPC. The current review discusses the global and regional distribution of NPC incidences, the risk factors associated with NPC, and the public health implications of these insights. Future investigations should consider international, large-scale prospective studies to elucidate the mechanisms underlying NPC pathogenesis and develop individualized interventions for NPC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chua, M. L. K., Wee, J. T. S., Hui, E. P., & Chan, A. T. C. (2016). Nasopharyngeal carcinoma. The Lancet, 387(10022), 1012–1024. https://doi.org/10.1016/S0140-6736(15)00055-0

    Article  Google Scholar 

  2. Chen, Y. P., Chan, A. T. C., Le, Q. T., Blanchard, P., Sun, Y., & Ma, J. (2019). Nasopharyngeal carcinoma. The Lancet, 394(10192), 64–80. https://doi.org/10.1016/S0140-6736(19)30956-0

    Article  Google Scholar 

  3. Guo, R., Mao, Y. P., Tang, L. L., Chen, L., Sun, Y., & Ma, J. (2019). The evolution of nasopharyngeal carcinoma staging. The British journal of radiology, 92(1102), 20190244. https://doi.org/10.1259/BJR.20190244

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lai, C., Zhang, C., Lv, H., Huang, H., Ke, X., Zhou, C., & Zhou, L. (2021). A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers. Cancer Medicine, 10(11), 3511. https://doi.org/10.1002/CAM4.3839

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Li, J., Chen, S., Peng, S., Liu, Y., Xing, S., He, X., & Chen, H. (2018). Prognostic nomogram for patients with nasopharyngeal carcinoma incorporating hematological biomarkers and clinical characteristics. International Journal of Biological Sciences, 14(5), 549. https://doi.org/10.7150/IJBS.24374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jen, C.-W., Tsai, Y.-C., Wu, J.-S., Chen, P.-L., Yen, J.-H., Chuang, W.-K., & Cheng, S.H.-C. (2020). Prognostic classification for patients with nasopharyngeal carcinoma based on American Joint Committee on Cancer staging system T and N categories. Therapeutic Radiology and Oncology, 4(0), 2–13. https://doi.org/10.21037/tro.2020.02.01

    Article  Google Scholar 

  7. Wu, Z.-X., Xiang, L., Rong, J.-F., He, H.-L., & Li, D. (2016). Nasopharyngeal carcinoma with headaches as the main symptom: A potential diagnostic pitfall. Journal of Cancer Research and Therapeutics, 12(1), 209–214. https://doi.org/10.4103/0973-1482.157334

    Article  CAS  PubMed  Google Scholar 

  8. Wang, K. H., Austin, S. A., Chen, S. H., Sonne, D. C., & Gurushanthaiah, D. (2017). Nasopharyngeal carcinoma diagnostic challenge in a nonendemic setting: Our experience with 101 patients. The Permanente Journal, 21, 16–180. https://doi.org/10.7812/TPP/16-180

    Article  PubMed  PubMed Central  Google Scholar 

  9. Jiromaru, R., Nakagawa, T., & Yasumatsu, R. (2022). Advanced nasopharyngeal carcinoma: Current and emerging treatment options. Cancer Management and Research, 14, 2681. https://doi.org/10.2147/CMAR.S341472

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ferlay, J, Ervik, M, Lam, F, Laversanne, M, Colombet, M, Mery L, Piñeros, M, Znaor, A, Soerjomataram, I., & Bray, F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today. Accessed 20 Feb 2024

  11. Xie, S. H., Yu, I. T. S., Tse, L. A., Mang, O. W. K., & Yue, L. (2013). Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983–2008: Suggestion of a potential protective role of oestrogen. European Journal of Cancer, 49(1), 150–155. https://doi.org/10.1016/j.ejca.2012.07.004

    Article  CAS  PubMed  Google Scholar 

  12. Zuo, X.-Y., Feng, Q.-S., Sun, J., Wei, P.-P., Chin, Y.-M., Guo, Y.-M., & Bei, J.-X. (2019). X-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma. Biology of Sex Differences, 10(1), 13–24. https://doi.org/10.1186/s13293-019-0227-9

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chen, Y., Chang, E. T., Liu, Z., Liu, Q., Cai, Y., Zhang, Z., & Ye, W. (2021). Residence characteristics and risk of nasopharyngeal carcinoma in southern China: A population-based case-control study. Environment International, 151, 106455. https://doi.org/10.1016/J.ENVINT.2021.106455

    Article  PubMed  Google Scholar 

  14. London, A. O., Gallagher, L. W., Sharma, R. K., Spielman, D., Golub, J. S., Overdevest, J. B., & Gudis, D. A. (2022). Impact of race, ethnicity, and socioeconomic status on nasopharyngeal carcinoma disease-specific and conditional survival. Seminars in Neurosurgery, 83(5), 451–460. https://doi.org/10.1055/S-0041-1741111

    Article  Google Scholar 

  15. Sung, H., Ferlay, J., Soerjomataram, I., Siegel, R. L., Bray, F., & Jemal, A. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(1), 7–33. https://doi.org/10.3322/caac.21660

    Article  Google Scholar 

  16. Bray, F., Bardot, A., Colombet, M., Mery, L., Pineros, M., Soerjomataram, I., Ferlay, J. (2023). Cancer Incidence in Five Continents, Vol. XII. https://ci5.iarc.who.int/.

  17. Ab Manan, A., Basri, H., Kau, N., Ab Rahman, S. Z., Amir, P. N., Ali, N., Abdul Aziz, A. (2019). Malaysia National Cancer Registry Report 2012–2016. Putrajaya. Retrieved from http://nci.moh.gov.my

  18. Linton, R. E., Daker, M., Khoo, A.S.-B., Chung, Y. C. D., Viljoen, M., & Neilsen, P. M. (2021). Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factors (Review). Oncology Letters, 22(1), 514–536. https://doi.org/10.3892/ol.2021.12775

    Article  PubMed  PubMed Central  Google Scholar 

  19. Wong, K. Y., Basri, H., Wong, Y. L., Wahab, M., HjKipli, N. P., Niap, I., & Ooi, C. H. (2023). Epidemiology of nasopharyngeal carcinoma in Sarawak, East Malaysia. Asian Pacific Journal of Cancer Prevention, 24, 2817–22. https://doi.org/10.31557/APJCP.2023.24.8.2817

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mathur, P., Sathishkumar, K., Chaturvedi, M., Das, P., Kondalli Sudarshan., L., ... Roselind, F. S. (2020). Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Global Oncology, 6, 1063–1075. https://doi.org/10.1200/GO.20.00122

    Article  PubMed  Google Scholar 

  21. Bray, F., Colombet, M., Mery, L., Pineros, M., Znaor, A., Zanetti, R., & Ferlay, J. (2021). Cancer Incidence in Five Continents (Vol. XI). IARC Publications.

    Google Scholar 

  22. Wang, Q., Xie, H., Li, Y., Theodoropoulos, N., Zhang, Y., Jiang, C., & Boffetta, P. (2022). Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans. International Journal of Cancer, 151(8), 1291–1303. https://doi.org/10.1002/ijc.34154

    Article  CAS  PubMed  Google Scholar 

  23. Yu, H., Yin, X., Mao, Y., Chen, M., Tang, Q., & Yan, S. (2021). The global burden of nasopharyngeal carcinoma from 2009 to 2019: An observational study based on the Global Burden of Disease Study 2019. European Archives of Oto-Rhino-Laryngology, 1, 3. https://doi.org/10.1007/s00405-021-06922-2

    Article  Google Scholar 

  24. Carioli, G., Negri, E., Kawakita, D., Garavello, W., La Vecchia, C., & Malvezzi, M. (2017). Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas. International Journal of Cancer, 140(10), 2256–2264. https://doi.org/10.1002/IJC.30660

    Article  CAS  PubMed  Google Scholar 

  25. Song, Y., Cheng, W., Li, H., & Liu, X. (2022). The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990–2019) and predictions to 2035. Cancer Medicine, 81, 4310. https://doi.org/10.1002/cam4.4783

    Article  Google Scholar 

  26. Noel, C. W., Sutradhar, R., Li, Q., Forner, D., Hallet, J., Cheung, M., & Eskander, A. (2020). Association of immigration status and Chinese and South Asian ethnicity with incidence of head and neck cancer. JAMA Otolaryngology - Head and Neck Surgery, 146(12), 1125–1135. https://doi.org/10.1001/JAMAOTO.2020.4197

    Article  PubMed  Google Scholar 

  27. Bray, F., Haugen, M., Moger, T. A., Tretli, S., Aalen, O. O., & Grotmol, T. (2008). Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications. Cancer Epidemiology, Biomarkers and Prevention, 17(9), 2356. https://doi.org/10.1158/1055-9965.EPI-08-0461

    Article  PubMed  Google Scholar 

  28. Lo, K. W., Chung, G. T. Y., & To, K. F. (2012). Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Seminars in Cancer Biology, 22(2), 79–86. https://doi.org/10.1016/j.semcancer.2011.12.011

    Article  CAS  PubMed  Google Scholar 

  29. Liu, Z., Chang, E. T., Liu, Q., Cai, Y., Zhang, Z., Chen, G., & Ye, W. (2017). Quantification of familial risk for nasopharyngeal carcinoma in a high-incidence area. Cancer, 123(14), 2716. https://doi.org/10.1002/CNCR.30643

    Article  CAS  PubMed  Google Scholar 

  30. Poh, S. S., Chua, M. L. K., & Wee, J. T. S. (2016). Carcinogenesis of nasopharyngeal carcinoma: An alternate hypothetical mechanism. Chinese Journal of Cancer, 35(1), 9. https://doi.org/10.1186/S40880-015-0068-9

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yang, -H., Cheng, T.-H., Chen, Y.-F., Lin, C.-S., Gaston, K., Yarbrough, W. G., & Lin, H.-C. (2023). Association of nasopharynx cancer with human papillomavirus infections. Cancers, 15(16), 4082. https://doi.org/10.3390/CANCERS15164082

    Article  PubMed  PubMed Central  Google Scholar 

  32. Huang Lin, J., Pang Wen, C., Qiang Jiang, C., Yuan, J.-M., Jen Chen, C., Yin Ho, S., & Lam, T.-H. (2021). Smoking and nasopharyngeal cancer: Individual data meta-analysis of six prospective studies on 334 935 men. International Journal of Epidemiology, 50(3), 975–986. https://doi.org/10.1093/ije/dyab060

    Article  Google Scholar 

  33. Xue, W.-Q., Qin, H.-D., Ruan, H.-L., Shugart, Y. Y., & Jia, W.-H. (2013). Quantitative association of tobacco smoking with the risk of nasopharyngeal carcinoma: A comprehensive meta-analysis of studies conducted between 1979 and 2011. American Journal of Epidemiology, 178(3), 325–338. https://doi.org/10.1093/aje/kws479

    Article  PubMed  PubMed Central  Google Scholar 

  34. Chang, E. T., Liu, Z., Hildesheim, A., Liu, Q., Cai, Y., Zhang, Z., & Ye, W. (2017). Active and passive smoking and risk of nasopharyngeal carcinoma: A population-based case-control study in southern China. American Journal of Epidemiology, 185(12), 1272–1280. https://doi.org/10.1093/aje/kwx018

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hu, T., Lin, C.-Y., Xie, S.-H., Chen, G.-H., Lu, Y.-Q., Ling, W., & Su-Mei Cao, C. (2019). Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein-Barr virus: An analysis of a prospective study in southern China. Cancer Medicine, 8, 2561–2571. https://doi.org/10.1002/cam4.2083

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Arfaeinia, H., Ghaemi, M., Jahantigh, A., Soleimani, F., & Hashemi, H. (2023). Secondhand and thirdhand smoke: A review on chemical contents, exposure routes, and protective strategies. Environmental Science and Pollution Research International, 1, 1. https://doi.org/10.1007/S11356-023-28128-1

    Article  Google Scholar 

  37. Szukalska, M., Szyfter, K., Florek, E., Rodrigo, J. P., Rinaldo, A., Mäkitie, A. A., & Ferlito, A. (2020). Electronic cigarettes and head and neck cancer risk-current state of art. Cancers, 12, 3274. https://doi.org/10.3390/cancers12113274

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Okekpa, S. I., Rabiatul Basria S M N Mydin, Mangantig, E., Azmi, N. S. A., Zahari, S. N. S., Kaur, G., & Musa, Y. (2019). Nasopharyngeal carcinoma (NPC) risk factors: A systematic review and meta-analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in Asian Region. Asian Pacific Journal of Cancer Prevention, 20(11), 3505–3514. https://doi.org/10.31557/APJCP.2019.20.11.3505

  39. Feng, R., Chang, E. T., Liu, Q., Cai, Y., Zhang, Z., Chen, G., & Ye, W. (2021). Intake of alcohol and tea and risk of nasopharyngeal carcinoma: A population-based case-control study in southern China. Cancer Epidemiology, Biomarkers and Prevention, 30(3), 545. https://doi.org/10.1158/1055-9965.EPI-20-1244

    Article  PubMed  Google Scholar 

  40. Secretan, B., Straif, K., Baan, R., Grosse, Y., El Ghissassi, F., & Bouvard, V. (2009). A review of human carcinogens - Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. The Lancet Oncology, 10(11), 1033–1034. https://doi.org/10.1016/S1470-2045(09)70326-2

    Article  PubMed  Google Scholar 

  41. Barrett, D., Ploner, A., Chang, E. T., Liu, Z., Zhang, C. X., Liu, Q., & Ye, W. (2019). Past and recent salted fish and preserved food intakes are weakly associated with nasopharyngeal carcinoma risk in adults in southern China. Journal of Nutrition, 149(9), 1596–1605. https://doi.org/10.1093/JN/NXZ095

    Article  PubMed  PubMed Central  Google Scholar 

  42. Feng, H., Zhou, Y., Wang, L., Wang, Y., Zhou, S., & Tian, F. (2022). Consumption of processed food and risk of nasopharyngeal carcinoma: A systematic review and meta-analysis. Translational Cancer Research, 11(4), 872–879. https://doi.org/10.21037/TCR-22-690/COIF

    Article  PubMed  PubMed Central  Google Scholar 

  43. Huang, C.-Y., Wu, S.-Y., Hsu, C.-C., & Chou, H.-Y. (2012). The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells. PLoS ONE, 7(9), 44810. https://doi.org/10.1371/journal.pone.0044810

    Article  ADS  CAS  Google Scholar 

  44. Mai, Z.-M., Kai-Cheong Ngan, R., Lai-Wan Kwong, D., Yuen, K.-T., Kai-Ming Ip, D., Chan, Y.-H., Lam, T.-H. (2021). Dietary fiber intake from fresh and preserved food and risk of nasopharyngeal carcinoma: Observational evidence from a Chinese population. Nutrition Journal, 20, 14. https://doi.org/10.1186/s12937-021-00667-8

  45. Lin, C., Cao, S.-M., Chang, E. T., Liu, Z., Cai, Y., Zhang, Z., & Ye, W. (2019). Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study. Cancer, 125, 4462–4470. https://doi.org/10.1002/cncr.32458

    Article  PubMed  Google Scholar 

  46. Chen, T., Ricardo Montor, W., Ho, S.-Y., Z-m, M., J-h, L., Rk-c, N., Lam, T.-H. (2019). Milk consumption across life periods in relation to lower risk of nasopharyngeal carcinoma: A multicentre case-control study. Frontiers in Oncology | www.frontiersin.org, 1, 253. https://doi.org/10.3389/fonc.2019.00253

  47. He, Y.-Q., Xue, W.-Q., Shen, G.-P., Tang, L.-L., Zeng, Y.-X., & Jia, W.-H. (2015). Household inhalants exposure and nasopharyngeal carcinoma risk: A large-scale case-control study in Guangdong. China. BMC Cancer, 15, 1022. https://doi.org/10.1186/s12885-015-2035-x

    Article  PubMed  Google Scholar 

  48. Chen, Y., Chang, E. T., Liu, Q., Cai, Y., Zhang, Z., Chen, G., ... Ye, W. (2021). Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study. Cancer, 127(15), 2724. https://doi.org/10.1002/cncr.33536

    Article  CAS  PubMed  Google Scholar 

  49. Yang, T., Liu, Y., Zhao, W., Chen, Z., & Deng, J. (2020). Association of ambient air pollution with nasopharyngeal carcinoma incidence in ten large Chinese cities, 2006–2013. International Journal of Environmental Research and Public Health, 17, 6. https://doi.org/10.3390/IJERPH17061824

    Article  Google Scholar 

  50. Meng, E., Yin, J., Jin, W., Mao, Y., Wu, Q., & Qiu, J. (2020). Wood dust exposure and risks of nasopharyngeal carcinoma: A meta-analysis. European Journal of Public Health, 30(4), 817–822. https://doi.org/10.1093/EURPUB/CKZ239

    Article  Google Scholar 

  51. Huang, H.-C., Tantoh, D. M., Hsu, S.-Y., Nfor, O. N., Lin Frank, C.-F., Lung, C.-C., & Liaw, Y.-P. (2020). Association between coarse particulate matter (PM 10–2.5) and nasopharyngeal carcinoma among Taiwanese men. J Investig Med, 68, 419–424. https://doi.org/10.1136/jim-2019-001119

    Article  PubMed  Google Scholar 

  52. Cao, S.-M., Chen, S.-H., Qian, C.-N., Liu, Q., & Xia, Y.-F. (2014). Familial nasopharyngeal carcinomas possess distinguished clinical characteristics in southern China. Chinese Journal of Cancer Research, 26(5), 543–549. https://doi.org/10.3978/j.issn.1000-9604.2014.10.03

    Article  PubMed  PubMed Central  Google Scholar 

  53. Ouyang, P.-Y., Su, Z., Mao, Y.-P., Liang, X.-X., Liu, Q., & Xie, F.-Y. (2013). Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinoma. British Journal of Cancer, 2013(109), 788–794. https://doi.org/10.1038/bjc.2013.343

    Article  CAS  Google Scholar 

  54. Siak, P. Y., Khoo, A.S.-B., Leong, C. O., Hoh, B.-P., & Cheah, S.-C. (2021). Current status and future perspectives about molecular biomarkers of nasopharyngeal carcinoma. Cancers, 13(14), 3490. https://doi.org/10.3390/cancers13143490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Ning, L., Mun-Yee Ko, J., Zhuoyou Yu, V., Yan Ng, H., King-Chi Chan, C., Tao, L., & Li Lung, M. (2020). Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci. Communications Biology, 3, 759. https://doi.org/10.1038/s42003-020-01487-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Liu, Z., Goldstein, A. M., Hsu, W.-L., Yu, K. J., Chien, Y.-C., Ko, J.-Y., & Hildesheim, A. (2019). Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC. Cancer Epidemiology, Biomarkers and Prevention, 28(10), 1682. https://doi.org/10.1158/1055-9965.EPI-19-0007

    Article  CAS  PubMed  Google Scholar 

  57. Yee Ko, J. M., Dai, W., Wun Wong, E. H., Kwong, D., Ng, W. T., Lee, A., & Li Lung, M. (2014). Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair. International Journal of Cancer, 135(7), 1634–1645. https://doi.org/10.1002/IJC.28802

    Article  PubMed  Google Scholar 

  58. Wang, T.-M., Xiao, R.-W., He, Y.-Q., Zhang, W.-L., Diao, H., Tang, M., & Jia, W.-H. (2023). High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma. The American Journal of Human Genetics. https://doi.org/10.1016/j.ajhg.2023.06.003

    Article  PubMed  Google Scholar 

  59. Wu, M.-Y., Huang, S.-J., Yang, F., Qin, X.-T., Liu, D., Ding, Y., & Wang, X.-C. (2017). Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology. Oncotarget, 8(32), 52708–23. https://doi.org/10.18632/oncotarget.17085

    Article  PubMed  PubMed Central  Google Scholar 

  60. Zhuo, X., Ye, H., Li, Q., Xiang, Z., & Zhang, X. (2016). Is MDM2 SNP309 variation a risk factor for head and neck carcinoma? Medicine, 95(9), e2948. https://doi.org/10.1097/MD.0000000000002948

    Article  PubMed  PubMed Central  Google Scholar 

  61. Wu, M., Huang, S., Liu, D., Peng, M., Yang, F., & Wang, X. (2016). Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysis. Molecular and Clinical Oncology, 4, 221–228. https://doi.org/10.3892/mco.2015.700

    Article  CAS  PubMed  Google Scholar 

  62. Sahu, S., Chakrabarti, S., Roy, S., Baishya, N., Reddy, R., Suklabaidya, S., & Choudhuri, T. (2016). Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: Evidence from a case-control study and meta-analysis. Oncogenesis, 5, 225. https://doi.org/10.1038/oncsis.2016.31

    Article  CAS  Google Scholar 

  63. Cao, L., Li, P., & Dong, L. (2017). Matrix metalloproteinase-1 (MMP-1) rs1799750 polymorphism is associated with nasopharyngeal carcinoma (NPC) risk. Cellular and Molecular Biology, 63(10), 1–3. https://doi.org/10.14715/cmb/2017.63.10.1

    Article  ADS  CAS  PubMed  Google Scholar 

  64. Li, Z., Ge, H., Xie, Y. G., Xie, G. Y., & Lv, C. (2015). Matrix metalloproteinase-1 (MMP1) polymorphism is associated with lowered risk of nasopharyngeal carcinoma in Asian population. Cell Biochemistry and Biophysics, 71(2), 999–1004. https://doi.org/10.1007/s12013-014-0299-4

    Article  CAS  PubMed  Google Scholar 

  65. Zheng, Y., Wang, M., Tian, T., Liu, K., Liu, X., Zhai, Y., & Lu, J. (2017). Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis. Oncotarget, 8(18), 29795–29807.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Xiao, T.-T., Li, X., Xu, Y., & Li, Y. (2018). Significant association of the cytokine variants with head and neck cancer risk: Evidence from meta-analysis. European Archives of Oto-Rhino-Laryngology, 275(3), 483–496. https://doi.org/10.1007/s00405-017-4820-4

    Article  PubMed  Google Scholar 

  67. Huang, C.-Y., Chang, W.-S., Tsai, C.-W., Hsia, T.-C., Shen, T.-C., Bau, D.-T., & Shui, H.-A. (2018). The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in Taiwan. Medicine, 97(36), e12135. https://doi.org/10.1097/MD.0000000000012135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Niu, Y., Zhou, G., Wang, Y., Qin, J., Ping, J., Zhang, Q., & Zhou, G. (2019). Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma. Journal of Cellular Biochemistry, 120(4), 6661–6670. https://doi.org/10.1002/jcb.27962

    Article  CAS  PubMed  Google Scholar 

  69. Zhang, H., Deng, S., Zhang, J., Zhu, G., Zhou, J., Ye, W., & Lu, S. (2021). Single nucleotide polymorphisms within NFKBIA are associated with nasopharyngeal carcinoma susceptibility in Chinese Han population. Cytokine, 138, 155356. https://doi.org/10.1016/j.cyto.2020.155356

    Article  CAS  PubMed  Google Scholar 

  70. Li, Q., Wang, J. M., Peng, Y., Zhang, S. H., Ren, T., Luo, H., & Wang, D. (2013). Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pacific Journal of Cancer Prevention, 14(9), 5145–5151. https://doi.org/10.7314/APJCP.2013.14.9.5145

    Article  PubMed  Google Scholar 

  71. Wang, T.-M., He, Y.-Q., Xue, W.-Q., Zhang, J.-B., Xia, Y.-F., Deng, C.-M., & Jia, W.-H. (2022). Whole-exome sequencing study of familial nasopharyngeal carcinoma and its implication for identifying high-risk individuals. Journal of the National Cancer Institute, 00(0), djac177. https://doi.org/10.1093/jnci/djac177

    Article  CAS  Google Scholar 

  72. Ban, E.-Z., Lye, M.-S., Pei Chong, P., Yap, Y.-Y., Ying Crystale Lim, S., & Abdul Rahman, H. (2017). Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia. PLos One, 12(11), e0187200. https://doi.org/10.1371/journal.pone.0187200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Yu, G., Hsu, W. L., Coghill, A. E., Yu, K. J., Wang, C. P., Lou, P. J., & Goldstein, A. M. (2019). Whole-exome sequencing of nasopharyngeal carcinoma families reveals novel variants potentially involved in nasopharyngeal carcinoma. Scientific Reports, 9(1), 9916. https://doi.org/10.1038/S41598-019-46137-4

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  74. Xie, Y., Wu, Y., Zhou, X., Yao, M., Ning, S., & Wei, Z. (2016). Association of polymorphisms hOgg1 rs1052133 and hMUTYh rs3219472 with risk of nasopharyngeal carcinoma in a chinese population. OncoTargets and Therapy, 9, 755–760. https://doi.org/10.2147/OTT.S95944

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Lin, J., Ye, Q., Wang, Y., Wang, Y., & Zeng, Y. (2018). Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis. Medicine, 97(32), e11852. https://doi.org/10.1097/MD.0000000000011852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Cui, Q., Zuo, X. Y., Lian, Y. F., Feng, Q. S., Xia, Y. F., He, C. Y., & Bei, J. X. (2016). Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: Evidence from a large-scale case-control study and a meta-analysis. Tumor Biology, 37(11), 14825–14830. https://doi.org/10.1007/s13277-016-5300-y

    Article  CAS  PubMed  Google Scholar 

  77. Wang, T.-M., Zhou, T., He, Y.-Q., Xue, W.-Q., Zhang, J.-B., Zheng, X.-H., ... Jia, W.-H. (2018). Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility. Cancer Medicine, 7, 6308–6316. https://doi.org/10.1002/cam4.1838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Chin, Y.-M., Mushiroda, T., Takahashi, A., Kubo, M., Krishnan, G., Yap, L.-F., & Ng, C.-C. (2015). HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese. International Journal of Cancer, 136, 678–687. https://doi.org/10.1002/ijc.29035

    Article  CAS  PubMed  Google Scholar 

  79. Tian, W., Zhu, F. M., Wang, W. Y., Cai, J. H., Zhang, W., Li, L. X., & Wang, F. (2015). Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China. Tissue Antigens, 86(1), 15–20. https://doi.org/10.1111/tan.12576

    Article  CAS  PubMed  Google Scholar 

  80. Tian, W., Zhu, F., Cai, J., Li, L., Jin, H., & Wang, W. (2020). Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma patients in Hunan province, southern China. International Journal of Cancer, 147, 1397–1404. https://doi.org/10.1002/ijc.32992

    Article  CAS  PubMed  Google Scholar 

  81. Yao, K., Yang, S., Shen, J., Zhang, R., & Li, L. (2017). HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: A meta-analysis. European Archives of Oto-Rhino-Laryngology, 274, 297–303. https://doi.org/10.1007/s00405-016-4264-2

    Article  PubMed  Google Scholar 

  82. Sun, N., & Wang, X. (2019). Correlation between COX-2 gene polymorphism and susceptibility to nasopharyngeal carcinoma. European Review for Medical and Pharmacological Sciences, 23, 5770–5778.

    CAS  PubMed  Google Scholar 

  83. Fu, J., Li, Z., & Li, N. (2018). The association between COX-2 gene rs5275 polymorphism and nasopharyngeal carcinoma risk. Pathology Research and Practice, 214(10), 1579–1582. https://doi.org/10.1016/j.prp.2018.07.028

    Article  CAS  PubMed  Google Scholar 

  84. Yang, L., Liu, B., Qiu, F., Huang, B., Li, Y., Huang, D., & Lu, J. (2014). The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection. Carcinogenesis, 35(1), 46–52. https://doi.org/10.1093/carcin/bgt314

    Article  CAS  PubMed  Google Scholar 

  85. Yang, Z.-H., Dai, Q., Gu, Y.-J., Guo, Q.-X., & Gong, L. (2012). Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Science, 103(4), 653–658. https://doi.org/10.1111/j.1349-7006.2012.02210.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Liao, W.-L., Chan, F.-C., Chang, K.-P., Chang, Y.-W., Chen, C.-H., Su, W.-H., & Chang, H.-H. (2021). Associations between ALDH genetic variants, alcohol consumption, and the risk of nasopharyngeal carcinoma in an East Asian population. Genes, 12, 1547. https://doi.org/10.3390/genes12101547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Singh, S. A., & Ghosh, S. K. (2019). Metabolic phase I (CYPs) and phase II (GSTs) gene polymorphisms and their interaction with environmental factors in nasopharyngeal cancer from the ethnic population of Northeast India. Pathology and Oncology Research, 25(1), 33–44. https://doi.org/10.1007/s12253-017-0309-0

    Article  CAS  PubMed  Google Scholar 

  88. Yao, K., Qin, H., Gong, L., Zhang, R., & Li, L. (2017). CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: A meta-analysis. European Archives of Oto-Rhino-Laryngology, 274, 253–259. https://doi.org/10.1007/s00405-016-4236-6

    Article  PubMed  Google Scholar 

  89. Li, Y., Wan, W., Li, T., Cao, J., & Xu, G. (2015). GSTMI null genotype may be associated with an increased nasopharyngeal cancer risk in South China: An updated meta-analysis and review. OncoTargets and Therapy, 8, 2479–2484. https://doi.org/10.2147/OTT.S89212

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Liu, R.-R., Chen, J.-C., Li, M.-D., Li, T., Tan, Y., & Zhang, M. (2015). A meta-analysis of glutathione S-transferase M1 and T1 genetic polymorphism in relation to susceptibility to nasopharyngeal carcinoma. Int J Clin Exp Med (Vol. 8).

  91. Siew Yong Low, J., Ming Chin, Y., Mushiroda, T., Kubo, M., Krishnan Govindasamy, G., Choo Pua, K., & Ching Ng, C. (2016). A genome wide study of copy number variation associated with nasopharyngeal carcinoma in Malaysian Chinese identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci. PLoS One, 11(1), e0145774. https://doi.org/10.1371/journal.pone.0145774

    Article  Google Scholar 

  92. Clemente, F. J., Cardona, A., Inchley, C. E., Peter, B. M., Jacobs, G., Pagani, L., & Kivisild, T. (2014). A selective sweep on a deleterious mutation in CPT1A in Arctic populations. The American Journal of Human Genetics, 95(5), 584–589. https://doi.org/10.1016/J.AJHG.2014.09.016

    Article  CAS  PubMed  Google Scholar 

  93. Qin, H.-D., Yao Shugart, Y., Bei, J.-X., Pan, Q.-H., Chen, L., Feng, Q.-S., & Jia, W.-H. (2011). Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Research, 71(18), 3000. https://doi.org/10.1158/0008-5472.CAN-10-0469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Mun-Yee Ko, J., Hiu-Ki Tsang, K., Dai, W., Sta Ana Choi, S., Man-Long Leong, M., Kai-Cheong Ngan, R., & Li Lung, M. (2018). Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese. International Journal of Cancer, 143, 2289–2298. https://doi.org/10.1002/ijc.31617

    Article  CAS  Google Scholar 

  95. Khan, G., Fitzmaurice, C., Naghavi, M., & Ahmed, L. A. (2020). Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017. British Medical Journal Open, 10(8), e037505. https://doi.org/10.1136/BMJOPEN-2020-037505

    Article  Google Scholar 

  96. Young, L. S., Yap, L. F., & Murray, P. G. (2016). Epstein-Barr virus: More than 50 years old and still providing surprises. Nature Reviews Cancer, 16(12), 789–802. https://doi.org/10.1038/nrc.2016.92

    Article  CAS  PubMed  Google Scholar 

  97. Luo, X., Hong, L., Cheng, C., Li, N., Zhao, X., Shi, F., & Cao, Y. (2018). DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma. Cell Death and Disease, 9(6), 619. https://doi.org/10.1038/S41419-018-0662-2

    Article  PubMed  PubMed Central  Google Scholar 

  98. Chen, Y.-R., Liu, M.-T., Chang, Y.-T., Wu, C.-C., Hu, C.-Y., & Chen, J.-Y. (2008). Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells. Journal of Virology, 82(16), 8124. https://doi.org/10.1128/JVI.00430-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Lung, R. W. M., Hau, P. M., Yu, K. H. O., Yip, K. Y., Tong, J. H. M., Chak, W. P., & Lo, K. W. (2018). EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. Journal of Pathology, 244(4), 394–407. https://doi.org/10.1002/PATH.5018

    Article  CAS  PubMed  Google Scholar 

  100. Pai, S., O’Sullivan, B., Abdul-Jabbar, I., Peng, J., Connoly, G., Khanna, R., & Thomas, R. (2007). Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunology and Cell Biology, 85(5), 370–377. https://doi.org/10.1038/sj.icb.7100046

    Article  CAS  PubMed  Google Scholar 

  101. Yao, M., Ohshima, K., Suzumiya, J., Kume, T., Shiroshita, T., & Kikuchi, M. (1997). Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Journal of Cancer, 72, 398–402. https://doi.org/10.1002/(sici)1097-0215(19970729)72:3%3c398::aid-ijc4%3e3.0.co;2-k

    Article  CAS  Google Scholar 

  102. Ogino, T., Moriai, S., Ishida, Y., Ishii, H., Katayama, A., Miyokawa, N., & Ferrone, S. (2007). Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma. International Journal of Cancer, 120(11), 2401–2410. https://doi.org/10.1002/IJC.22334

    Article  CAS  PubMed  Google Scholar 

  103. Lai, H. C., Hsiao, J. R., Chen, C. W., Wu, S. Y., Lee, C. H., Su, I. J., & Chang, Y. (2010). Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines. Virology, 405(2), 464–473. https://doi.org/10.1016/J.VIROL.2010.06.037

    Article  CAS  PubMed  Google Scholar 

  104. Wu, L., Li, C., & Pan, L. (2018). Nasopharyngeal carcinoma: A review of current updates. Experimental and Therapeutic Medicine, 15(4), 3687–3692. https://doi.org/10.3892/ETM.2018.5878/HTML

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Liu, Z., Fang, F., Chang, E. T., Adami, H.-O., & Ye, W. (2016). Sibship size, birth order and risk of nasopharyngeal carcinoma and infectious mononucleosis: a nationwide study in Sweden. International Journal of Epidemiology, 45(3), 825–834. https://doi.org/10.1093/ije/dyv038

    Article  PubMed  Google Scholar 

  106. da Costa, V. G., Marques-Silva, A. C., & Moreli, M. L. (2015). The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: A meta-analysis of observational studies. Systematic Reviews, 4, 46. https://doi.org/10.1186/s13643-015-0037-z

    Article  PubMed  PubMed Central  Google Scholar 

  107. Xue, W.-Q., Wang, T.-M., Huang, J.-W., Zhang, J.-B., He, Y.-Q., Wu, Z.-Y., & Jia, W.-H. (2021). A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China. Virus Evolution, 7(1), 10. https://doi.org/10.1093/ve/veab010

    Article  Google Scholar 

  108. Shimizu, Y., Murakami, N., Mori, T., Takahashi, K., Kubo, Y., Yoshimoto, S., ... Itami, J. (2022). Clinical impact of p16 positivity in nasopharyngeal carcinoma. Laryngoscope Investigative. Otolaryngology, 7, 994–1001. https://doi.org/10.1002/lio2.832

    Article  PubMed  PubMed Central  Google Scholar 

  109. Petrelli, F., Dal Cin, E., Ghidini, A., Carioli, D., Falasca, V., De Stefani, A., & Capriotti, V. (2023). Human papillomavirus infection and non-oropharyngeal head and neck cancers: An umbrella review of meta-analysis. European Archives of Oto-Rhino-Laryngology, 1, 3. https://doi.org/10.1007/s00405-023-08027-4

    Article  Google Scholar 

  110. Stenmark, M. H., McHugh, J. B., Schipper, M., Walline, H. M., Komarck, C., Feng, F. Y., & Carey, T. E. (2014). Nonendemic HPV-positive nasopharyngeal carcinoma: Association with poor prognosis. International journal of radiation oncology, biology, physics, 88(3), 580. https://doi.org/10.1016/J.IJROBP.2013.11.246

    Article  PubMed  PubMed Central  Google Scholar 

  111. Ye, Y.-F., Xiang, Y.-Q., Fang, F., Gao, R., Zhang, L.-F., Xie, S.-H., & Cao, S.-M. (2015). Hepatitis B virus infection and risk of nasopharyngeal carcinoma in southern China. Cancer Epidemiology, Biomarkers & Prevention, 24(11), 1766. https://doi.org/10.1158/1055-9965.EPI-15-0344

    Article  Google Scholar 

  112. Liu, X., Li, X., Jiang, N., Lei, Y., Tang, L. L., Chen, L., & Ma, J. (2014). Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: Analysis of 1301 patients from an endemic area in China. Cancer, 120(1), 68–76. https://doi.org/10.1002/cncr.28377

    Article  PubMed  Google Scholar 

  113. Ahmed, H. G., Suliman, R. S. A., Ashankyty, I. M., Albieh, Z., & Warille, A. (2018). Role of human Cytomegalovirus in the etiology of nasopharyngeal carcinoma. Journal of Cancer Research and Therapeutics, 14(3), 583–586. https://doi.org/10.4103/0973-1482.176175

    Article  CAS  PubMed  Google Scholar 

  114. Shebl, F. M., Bhatia, K., & Engels, E. A. (2010). Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. International Journal of Cancer, 126, 2503–2508. https://doi.org/10.1002/ijc.24930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Purgina, B., Pantanowitz, L., & Seethala, R. R. (2011). A review of carcinomas arising in the head and neck region in HIV-positive patients. Pathology Research International, 2011, 1–12. https://doi.org/10.4061/2011/469150

    Article  Google Scholar 

  116. Riley, C. A., Marino, M. J., Hawkey, N., Lawlor, C. M., & McCoul, E. D. (2016). Sinonasal tract inflammation as a precursor to nasopharyngeal carcinoma: A systematic review and meta-analysis. Otolaryngology - Head and Neck Surgery (United States), 154(5), 810–816. https://doi.org/10.1177/0194599816629436

    Article  Google Scholar 

  117. Lin, K., Zeng, Z., Li, X., Chen, W., Lin, D., Xie, S., ... Du, J. (2023). Association between hypertension and Epstein- Barr virus reactivation among the population in a high-risk area for nasopharyngeal carcinoma. Virus Research, 331, 199117. https://doi.org/10.1016/j.virusres.2023.199117

  118. Tseng, K.-S., Lin, C., Lin, Y.-S., & Weng, S.-F. (2014). Risk of head and neck cancer in patients with diabetes mellitus: A retrospective cohort study in Taiwan. JAMA Otolaryngology - Head and Neck Surgery, 140(8), 746–753. https://doi.org/10.1001/jamaoto.2014.1258

    Article  PubMed  Google Scholar 

  119. Feng, R., Chang, E. T., Liu, Z., Liu, Q., Cai, Y., Zhang, Z., & Ye, W. (2019). Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population-based case–control study in southern China. Cancer Medicine, 8(4), 1835. https://doi.org/10.1002/CAM4.2027

    Article  PubMed  PubMed Central  Google Scholar 

  120. Liu, Q.-Y., Liao, Y., Wu, Y.-X., Diao, H., Du, Y., Chen, Y.-W., & Jia, W.-H. (2023). The oral microbiome as mediator between oral hygiene and its impact on nasopharyngeal carcinoma. Microorganisms, 11, 719. https://doi.org/10.3390/microorganisms11030719

    Article  PubMed  PubMed Central  Google Scholar 

  121. Liao, Y., Zhang, J.-B., Lu, L.-X., Jia, Y.-J., Zheng, M.-Q., Debelius, J. W., & Li, J. (2023). Oral microbiota alteration and roles in Epstein-Barr virus reactivation in nasopharyngeal carcinoma. Microbiology Spectrum, 11, 1. https://doi.org/10.1128/SPECTRUM.03448-22

    Article  Google Scholar 

  122. Hao, Y., Zeng, Z., Peng, X., Ai, P., Han, Q., Ren, B., & Rui Ma, C. (2022). The human oral-nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma. Front. Cell. Infect. Microbiol, 12, 1013920. https://doi.org/10.3389/fcimb.2022.1013920

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Gupta, V. K., Paul, S., & Dutta, C. (2017). Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Frontiers in Microbiology, 8(1), 237451. https://doi.org/10.3389/FMICB.2017.01162/BIBTEX

    Article  Google Scholar 

  124. Zhong, L., Krummenacher, C., Zhang, W., Hong, J., Feng, Q., Chen, Y., & Zhang, X. (2022). Urgency and necessity of Epstein-Barr virus prophylactic vaccines. Vaccines, 7(1), 159. https://doi.org/10.1038/S41541-022-00587-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Coghill, A. E., Bu, W., Nguyen, H., Hsu, W. L., Yu, K. J., Lou, P. J., & Cohen, J. I. (2016). High levels of antibody that neutralize b-cell infection of Epstein-Barr virus and that bind ebv gp350 are associated with a lower risk of nasopharyngeal carcinoma. Clinical Cancer Research, 22, 14. https://doi.org/10.1158/1078-0432.CCR-15-2299

    Article  CAS  Google Scholar 

  126. Zhu, Q.-Y., Kong, X.-W., Sun, C., Xie, S.-H., Hildesheim, A., Cao, S.-M., & Zeng, M.-S. (2020). Association between antibody responses to Epstein-Barr virus glycoproteins, neutralization of infectivity, and the risk of nasopharyngeal carcinoma. mSphere, 5, 6. https://doi.org/10.1128/msphere.00901-20

    Article  CAS  Google Scholar 

  127. Ji, M. F., Sheng, W., Cheng, W. M., Ng, M. H., Wu, B. H., Yu, X., & Cao, S. M. (2019). Incidence and mortality of nasopharyngeal carcinoma: Interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Annals of Oncology, 30(10), 1630–1637. https://doi.org/10.1093/annonc/mdz231

    Article  CAS  PubMed  Google Scholar 

  128. Zheng, X. H., Lu, L. X., Li, X. Z., & Jia, W. H. (2015). Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China. Cancer Science, 106(9), 1196–1201. https://doi.org/10.1111/CAS.12718

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Yang, X., Dai, W., Kwong, D. L. W., Szeto, C. Y. Y., Wong, E. H. W., Ng, W. T., & Lung, M. L. (2015). Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. International Journal of Cancer, 136, 4. https://doi.org/10.1002/ijc.29192

    Article  CAS  Google Scholar 

  130. King, A. D., Vlantis, A. C., Yuen, T. W. C., Law, B. K. H., Bhatia, K. S., Zee, B. C. Y., & Ahuja, A. T. (2015). Detection of nasopharyngeal carcinoma by MR imaging: Diagnostic accuracy of MRI compared with endoscopy and endoscopic biopsy based on long-term follow-up. American Journal of Neuroradiology, 36, 12. https://doi.org/10.3174/ajnr.A4456

    Article  Google Scholar 

  131. Chan, J. Y. K., Yeung, D. C. M., Vlantis, A. C., Wong, E. W. Y., & Tong, M. C. F. (2018). A meta-analysis of narrowband imaging for the diagnosis of primary nasopharyngeal carcinoma [version 1; referees: 2 approved]. F1000Research, 7, 759. https://doi.org/10.12688/f1000research.15183.1

  132. Yang, X., Wu, J., & Chen, X. (2023). Application of artificial intelligence to the diagnosis and therapy of nasopharyngeal carcinoma. Journal of Clinical Medicine. https://doi.org/10.3390/jcm12093077

    Article  PubMed  PubMed Central  Google Scholar 

  133. Chu, Y. W., Chen, F., Tang, Y., Chen, T., Yu, Y. X., Jin, H. L., & Zeng, X. Y. (2018). Diagnosis of nasopharyngeal carcinoma from serum samples using hyperspectral imaging combined with a chemometric method. Optics Express, 26, 22. https://doi.org/10.1364/oe.26.028661

    Article  CAS  Google Scholar 

  134. Colevas, A. D., Yom, S. S., Pfister, D. G., Spencer, S., Adelstein, D., Adkins, D., & Darlow, S. D. (2018). NCCN guidelines ® insights: Head and neck cancers, version 1 .2018 featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network, 16(5), 479–490. https://doi.org/10.6004/jnccn.2018.0026

    Article  PubMed  Google Scholar 

  135. Liu, Z., Chen, Y., Su, Y., Hu, X., & Peng, X. (2021). Nasopharyngeal carcinoma: Clinical achievements and considerations among treatment options. Frontiers in Oncology, 11, 635737. https://doi.org/10.3389/fonc.2021.635737

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Liao, K.-C., Chuang, H.-C., Chien, C.-Y., Lin, Y.-T., Tsai, M.-H., Su, Y.-Y., & Wong, D. (2021). Quality of life as a mediator between cancer stage and long-term mortality in nasopharyngeal cancer patients treated with intensity-modulated radiotherapy. Cancers, 13, 5063. https://doi.org/10.3390/cancers13205063

    Article  PubMed  PubMed Central  Google Scholar 

  137. Ku, P. K. M., Vlantis, A. C., Wong, R. W. M., Hui, T. S. C., Law, T., Ng, L. K. Y., & Tong, M. C. F. (2023). Quality of life and swallowing outcomes after early proactive swallowing rehabilitation by either transcutaneous neuromuscular electrical stimulation or exercise-based swallowing training in patients with nasopharyngeal carcinoma after radiotherapy. Laryngoscope Investigative Otolaryngology, 8(6), 1532–1546. https://doi.org/10.1002/LIO2.1162

    Article  PubMed  PubMed Central  Google Scholar 

  138. Chan, K. C. A., Woo, J. K. S., King, A., Zee, B. C. Y., Lam, W. K. J., Chan, S. L., & Lo, Y. M. D. (2017). Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. The New England Journal of Medicine, 377(6), 513–522. https://doi.org/10.1056/NEJMoa1701717

    Article  CAS  PubMed  Google Scholar 

  139. Yu, X., Ji, M., Cheng, W., Wu, B., Du, Y., & Cao, S. (2018). Assessment of the long-term diagnostic performance of a new serological screening scheme in large-scale nasopharyngeal carcinoma screening. Journal of Cancer, 9(12), 2093–2097. https://doi.org/10.7150/jca.23755

    Article  PubMed  PubMed Central  Google Scholar 

  140. Tan, G. W., Sivanesan, V. M., Abdul Rahman, F. I., Hassan, F., Hasbullah, H. H., Ng, C. C., & Tan, L. P. (2019). A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma. International Journal of Cancer, 145(8), 2260–2266. https://doi.org/10.1002/IJC.32173

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Li, T., Guo, X., Ji, M., Li, F., Wang, H., Cheng, W., & Xia, N. (2018). Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma. Cancer Medicine, 7(4), 1458. https://doi.org/10.1002/CAM4.1345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Lam, W. K. J., Jiang, P., Chan, K. C. A., Cheng, S. H., Zhang, H., Peng, W., & Lo, Y. M. D. (2018). Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 115(22), E5115–E5124. https://doi.org/10.1073/PNAS.1804184115/-/DCSUPPLEMENTAL

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  143. Lao, T. D., Thieu, H. H., Nguyen, D. H., & Le, T. A. H. (2022). Hypermethylation of the RASSF1A gene promoter as the tumor DNA marker for nasopharyngeal carcinoma. International Journal of Biological Markers, 37, 1. https://doi.org/10.1177/17246008211065472

    Article  CAS  Google Scholar 

  144. Zhang, J., Shen, Z., Liu, H., Liu, S., & Shu, W. (2018). Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma. Cancer Management and Research, 10, 2953–2964. https://doi.org/10.2147/CMAR.S171796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Harris, J. P., Saraswathula, A., Kaplun, B., Qian, Y., Chan, K. C. A., Chan, A. T. C., & Pollom, E. (2019). Cost-effectiveness of screening for nasopharyngeal carcinoma among Asian American Men in the United States. Otolaryngology--Head and Neck Surgery, 161(1), 82–90. https://doi.org/10.1177/0194599819832593

    Article  PubMed  Google Scholar 

  146. Miller, J. A., Le, Q. T., Pinsky, B. A., & Wang, H. (2021). Cost-effectiveness of nasopharyngeal carcinoma screening with Epstein-Barr virus polymerase chain reaction or serology in high-incidence populations Worldwide. Journal of the National Cancer Institute, 113(7), 852–862. https://doi.org/10.1093/JNCI/DJAA198

    Article  PubMed  Google Scholar 

  147. He, Y. Q., Wang, T. M., Ji, M., Mai, Z. M., Tang, M., Wang, R., & Jia, W. H. (2022). A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening. Nature Communications, 13(1), 1–10. https://doi.org/10.1038/s41467-022-29570-4

    Article  CAS  Google Scholar 

  148. Jiang, C., Chen, J., Xie, S., Zhang, L., Xiang, Y., Lung, M., & Guan, X. Y. (2018). Evaluation of circulating EBV microRNA BART2–5p in facilitating early detection and screening of nasopharyngeal carcinoma. International Journal of Cancer, 143(12), 3209–3217. https://doi.org/10.1002/IJC.31642

    Article  CAS  PubMed  Google Scholar 

  149. Gao, W., Wong, T. S., Lv, K. X., Zhang, M. J., Tsang, R. K. Y., & Chan, J. Y. W. (2019). Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Head and Neck, 41(3), 780–792. https://doi.org/10.1002/hed.25544

    Article  PubMed  Google Scholar 

  150. Lu, T., Guo, Q., Lin, K., Chen, H., Chen, Y., Xu, Y., & Pan, J. (2020). Circulating Epstein-Barr virus microRNAs BART7–3p and BART13–3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Science, 111(5), 1711–1723. https://doi.org/10.1111/cas.14381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. Coghill, A. E., Pfeiffer, R. M., Proietti, C., Hsu, W. L., Chien, Y. C., Lekieffre, L., & Doolan, D. L. (2018). Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan. Clinical cancer research, 24(6), 1305. https://doi.org/10.1158/1078-0432.CCR-17-1929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Gong, R., Yang, C., Abbas, G., Wang, D., Zhang, X., Nie, G., & Ding, H. (2023). Diagnosis of nasopharyngeal carcinoma using an ultrasensitive immunoassay method based on nanoparticles. Nanoscale, 15(7), 3475–3481. https://doi.org/10.1039/D2NR05848K

    Article  CAS  PubMed  Google Scholar 

  153. Juarez, P. D., & Matthews-Juarez, P. (2018). Applying an exposome-Wide (ExWAS) approach to cancer research. Frontiers in Oncology, 8, 313. https://doi.org/10.3389/FONC.2018.00313

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The work was supported by a grant from the Ministry of Higher Education (MOHE) through the Fundamental Research Grant Scheme (FGRS/1/2020/SKK0/UCSI/02/2) and UCSI University Research Excellence and Innovation Grant (REIG-FMS-2020/009).

Author information

Authors and Affiliations

Authors

Contributions

ZYS, PYS, and S-CC were involved in the conceptualization and design of the content. ZYS wrote and revised the manuscript. PYS, YYL, and S-CC reviewed and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Shiau-Chuen Cheah.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, Z.Y., Siak, P.Y., Lwin, Y.Y. et al. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev (2024). https://doi.org/10.1007/s10555-024-10176-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10555-024-10176-9

Keywords

Navigation